Pharmaceutical Business review

Insight Pharmaceuticals recalls nasal decongestant over bacterial contamination

Internal investigations revealed the presence of a microbial contaminant that exceeds the product specifications which may subsequently result in a subpar product.

The product bearing the UPC Code, 6373673005, was distributed in the US through retail outlets and pharmacies.

Burkholderia cepacia can cause serious infection in individuals with a weak immune system or chronic lung condition.

The company, however, said that no illnesses have been reported.